These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17667965)

  • 1. Association between FAS polymorphism and prostate cancer development.
    Lima L; Morais A; Lobo F; Calais-da-Silva FM; Calais-da-Silva FE; Medeiros R
    Prostate Cancer Prostatic Dis; 2008; 11(1):94-8. PubMed ID: 17667965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
    Zhang Z; Xue H; Gong W; Wang M; Yuan L; Han S; Zhang Z
    Carcinogenesis; 2009 Mar; 30(3):487-93. PubMed ID: 19168581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z; Wang LE; Sturgis EM; El-Naggar AK; Hong WK; Amos CI; Spitz MR; Wei Q
    Clin Cancer Res; 2006 Sep; 12(18):5596-602. PubMed ID: 17000697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
    Cao Y; Miao XP; Huang MY; Deng L; Lin DX; Zeng YX; Shao JY
    Mol Carcinog; 2010 Nov; 49(11):944-50. PubMed ID: 20842669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARE-I polymorphism on PSA gene in prostate cancer patients of a Turkish population.
    Kalay E; Ergen A; Narter F; Agaçhan B; Görmüs U; Yigit N; Isbir T
    Anticancer Res; 2009 Apr; 29(4):1395-8. PubMed ID: 19414393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels.
    Mahfoudh W; Bel Hadj Jrad B; Romdhane A; Chouchane L
    Int J Immunogenet; 2007 Jun; 34(3):209-12. PubMed ID: 17504511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
    Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
    Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
    Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
    Goto T; Nakano M; Ito S; Ehara H; Yamamoto N; Deguchi T
    Urology; 2007 Jul; 70(1):127-30. PubMed ID: 17656222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of Fas and Fas ligand in preterm premature rupture of membranes in singleton pregnancies.
    Fuks A; Parton LA; Polavarapu S; Netta D; Strassberg S; Godi I; Hsu CD
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1132-6. PubMed ID: 16157125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia.
    Farre L; Bittencourt AL; Silva-Santos G; Almeida A; Silva AC; Decanine D; Soares GM; Alcantara LC; Van Dooren S; Galvão-Castro B; Vandamme AM; Van Weyenbergh J
    J Leukoc Biol; 2008 Jan; 83(1):220-2. PubMed ID: 17962369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients.
    Teixeira AL; Ribeiro R; Cardoso D; Pinto D; Lobo F; Fraga A; Pina F; Calais-da-Silva F; Medeiros R
    Clin Cancer Res; 2008 Jun; 14(11):3367-71. PubMed ID: 18519765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Fas gene promoter polymorphism in cervical cancer patients.
    Dybikowska A; Sliwinski W; Emerich J; Podhajska AJ
    Int J Mol Med; 2004 Sep; 14(3):475-8. PubMed ID: 15289903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between juvenile idiopathic arthritis and fas gene polymorphism.
    Donn R; Zeggini E; Shelley E; Ollier W; Thomson W;
    J Rheumatol; 2002 Jan; 29(1):166-8. PubMed ID: 11824955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of FAS -1377 G>A and FAS -670 A>G functional polymorphisms of FAS gene of cell death pathway with recurrent early pregnancy loss risk.
    Nair RR; Khanna A; Singh K
    J Reprod Immunol; 2012 Mar; 93(2):114-8. PubMed ID: 22386066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between Fas A/G polymorphism and therapeutic effects induced by methimazole treatment for Graves' disease in Northern Chinese.
    Li P; Li Q; Chen L; Sun Y; Zhang J
    Pharmazie; 2008 Oct; 63(10):748-50. PubMed ID: 18972838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.